REGENXBIO Inc. Profile Avatar - Palmy Investing

REGENXBIO Inc.

REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapy product candidates to deliver genes to cells to address genetic defects or to enable cells in the body to produce therapeutic proteins or antibodies that are intended to impact…

Biotechnology
US, Rockville [HQ]

Government Awards Analysis Beta

Obligations Over-Time

Awards
Obligations

REGENXBIO Inc. has no obligation with a government/award agency.

Latest Obligations

Contracts
$ 0.0
IDVs
$ 0.0
Direct Payments
$ 0.0
Grants
$ 0.0
Loans
$ 0.0
Other Payments
$ 0.0
vs. Previous FY
Contracts
$ 0.0
IDVs
$ 0.0
Direct Payments
$ 0.0
Grants
$ 0.0
Loans
$ 0.0
Other Payments
$ 0.0

Spending By Type

Awards
Obligations

REGENXBIO Inc. can't present spending by time.

Get PRO Today

With PRO you will unlock all insights related to government awards of REGENXBIO Inc..

End of RGNX's Analysis
CIK: 1590877 CUSIP: 75901B107 ISIN: US75901B1070 LEI: - UEI: -
Secondary Listings
RGNX has no secondary listings inside our databases.